Atossa_Therapeutics_logo-min.png
Atossa Therapeutics to Present at the BTIG Virtual Biotechnology Conference on August 9-10, 2021
05 août 2021 09h30 HE | Atossa Therapeutics, Inc.
SEATTLE, Aug. 05, 2021 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS), a clinical stage biopharmaceutical company seeking to discover and develop innovative medicines in areas of...
Logo_final_color.png
Cybrexa Therapeutics to Present at BTIG Virtual Biotechnology Conference 2021
04 août 2021 11h50 HE | Cybrexa Therapeutics
NEW HAVEN, Conn., Aug. 04, 2021 (GLOBE NEWSWIRE) -- Cybrexa Therapeutics, an oncology-focused biotechnology company developing a new class of therapeutics through its alphalex™ Peptide Drug...
BioCardia-Final-Logo-2016-JPEG.jpg
BioCardia to Participate in a Fireside Chat at the BTIG Virtual Biotechnology Conference on August 10, 2021
04 août 2021 08h00 HE | BioCardia, Inc.
SAN CARLOS, Calif., Aug. 04, 2021 (GLOBE NEWSWIRE) -- BioCardia®, Inc. (Nasdaq: BCDA), a leader in the development of comprehensive solutions for cardiovascular and pulmonary cell based therapies,...